Predictors and impact of time to clinical stability in community-acquired pneumococcal pneumonia

Respiratory Medicine

Volumn 108, Issue 5, 2014, Pages 806-812

  Takada, Kazuto ^a   Matsumoto, Shuuichi ^a   Kojima, Eiji ^a   Iwata, Susumu ^a   Ninomiya, Kiyoko ^a   Tanaka, Kentarou ^a   Goto, Daiki ^a   Shimizu, Takahiro ^a   Nohara, Kango ^a  

^a KOMAKI CITY HOSPITAL   (Japan)

Author keywords

Clinical stability; Community acquired pneumonia; Pneumococcal pneumonia; Predictor

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

AGED; AREA UNDER THE CURVE; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PILOT STUDY; PNEUMONIA SEVERITY INDEX; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL CONCEPTS; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS PNEUMONIA; TIME TO CLINICAL STABILITY; VERY ELDERLY; BACTEREMIA; BLOOD; COMMUNITY-ACQUIRED INFECTIONS; METABOLISM; PNEUMONIA, PNEUMOCOCCAL; PROGNOSIS; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; TIME;

AGED; AGED, 80 AND OVER; BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; PILOT PROJECTS; PNEUMONIA, PNEUMOCOCCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84899471194     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.02.007     Document Type: Article

References (35)

1. J.A. Ramirez, L. Srinath, S. Ahkee, A. Huang, and M.J. Raff Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia Arch Intern Med 155 1995 1273 1276
2. J.A. Ramirez, S. Vargas, G.W. Ritter, M.E. Brier, A. Wright, and S. Smith et al. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia Arch Intern Med 159 1999 2449 2454 (Pubitemid 29526773)
3. S. Aliberti, P. Peyrani, G. Filardo, M. Mirsaeidi, A. Amir, and F. Blasi et al. Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia Chest 140 2011 482 488
4. E.A. Halm, M.J. Fine, W.N. Kapoor, D.E. Singer, T.J. Marrie, and A.L. Siu Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia Arch Intern Med 162 2002 1278 1284 (Pubitemid 34595034)
5. A. Capelastegui, P.P. España, A. Bilbao, M. Martinez-Vazquez, I. Gorordo, and M. Oribe et al. Pneumonia: criteria for patient instability on hospital discharge Chest 134 2008 595 600
6. R. Menéndez, A. Torres, F. Rodríguez de Castro, R. Zalacaín, J. Aspa, and J.J. Martín Villasclaras et al. Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients Clin Infect Dis 39 2004 1783 1790 (Pubitemid 39657257)
7. E.A. Halm, M.J. Fine, T.J. Marrie, C.M. Coley, W.N. Kapoor, and D.S. Obrosky et al. Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines J Am Med Assoc 279 1998 1452 1457 (Pubitemid 28228202)
8. F.W. Arnold, G.N. Brock, P. Peyrani, E.L. Rodríguez, A.A. Díaz, and P. Rossi et al. Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study Respir Med 104 2010 1736 1743
9. J. Bordón, P. Peyrani, G.N. Brock, F. Blasi, J. Rello, and T. File et al. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study Chest 133 2008 618 624 (Pubitemid 351367368)
10. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383 (Pubitemid 17055592)
11. R.P. Moreno, P.G. Metnitz, E. Almeida, B. Jordan, P. Bauer, and R.A. Campos et al. SAPS 3 - from evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission Intensive Care Med 31 2005 1345 1355 (Pubitemid 41437728)
12. N. Miyashita, T. Matsushima, M. Oka Japanese Respiratory Society The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations Intern Med 45 2006 419 428 (Pubitemid 43676577)
13. M.J. Fine, T.E. Auble, D.M. Yealy, B.H. Hanusa, L.A. Weissfeld, and D.E. Singer et al. A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 1997 243 250 (Pubitemid 27044625)
14. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing: ninth informational supplement. M100-S9 1999 National Committee for Clinical Laboratory Standards
15. L.A. Mandell, R.G. Wunderink, A. Anzueto, J.G. Bartlett, G.D. Campbell, and N.C. Dean et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44 Suppl. 2 2007 S27 S72
16. N. Roche, M. Zureik, D. Soussan, F. Neukirch, D. Perrotin Urgence BPCO (COPD Emergency) Scientific Committee Predictors of outcomes in COPD exacerbation cases presenting to the emergency department Eur Respir J 32 2008 953 961
17. S. Aliberti, A.M. Zanaboni, T. Wiemken, A. Nahas, S. Uppatla, and L.C. Morlacchi et al. Criteria for clinical stability in hospitalised patients with community-acquired pneumonia Eur Respir J 42 2013 742 749
18. A.R. Akram, J.D. Chalmers, J.K. Taylor, J. Rutherford, A. Singanayagam, and A.T. Hill An evaluation of clinical stability criteria to predict hospital course in community-acquired pneumonia Clin Microbiol Infect 2013; Feb 26 10.1111/1469-0691.12173 [Epub ahead of print]
19. R. el Moussaoui, C.A. de Borgie, P. van den Broek, W.N. Hustinx, P. Bresser, and G.E. van den Berk et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study Br Med J 332 2006 1355
20. G. Choudhury, P. Mandal, A. Singanayagam, A.R. Akram, J.D. Chalmers, and A.T. Hill Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia-a propensity-adjusted analysis Clin Microbiol Infect 17 2011 1852 1858
21. J.A. Ramirez, and J. Bordon Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia Arch Intern Med 161 2001 848 850 (Pubitemid 32225393)
22. M.S. Niederman, L.A. Mandell, A. Anzueto, J.B. Bass, W.A. Broughton, and G.D. Campbell et al. Guideline for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention Am J Respir Crit Care Med 163 2001 1730 1754 (Pubitemid 32578779)
23. B. Rosón, J. Carratalà, N. Fernández-Sabé, F. Tubau, F. Manresa, and F. Gudiol Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia Arch Intern Med 164 2004 502 508 (Pubitemid 38314445)
24. M. Hoogewerf, J.J. Oosterheert, E. Hak, I.M. Hoepelman, and M.J. Bonten Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia Clin Microbiol Infect 12 2006 1097 1104 (Pubitemid 44462844)
25. S. Aliberti, A. Amir, P. Peyrani, M. Mirsaeidi, M. Allen, and B.K. Moffett Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia Chest 134 2008 955 962
26. R. Menéndez, A. Torres, R. Zalacaín, J. Aspa, J.J. Martín Villasclaras, and L. Borderías et al. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome Thorax 59 2004 960 965 (Pubitemid 39490781)
27. R. Menéndez, M. Cavalcanti, S. Reyes, J. Mensa, R. Martinez, and M.A. Marcos et al. Markers of treatment failure in hospitalised community acquired pneumonia Thorax 63 2008 447 452 (Pubitemid 351692355)
28. C. Cillóniz, S. Ewig, E. Polverino, C. Muñoz-Almagro, F. Marco, and A. Gabarrús et al. Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes Clin Microbiol Infect 18 2012 1134 1142
29. C. Feldman, and R. Anderson Bacteraemic pneumococcal pneumonia: current therapeutic options Drugs 71 2011 131 153
30. D.M. Musher, I. Alexandraki, E.A. Graviss, N. Yanbeiy, A. Eid, and L.A. Inderias et al. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study Med Baltim 79 2000 210 221 (Pubitemid 30618052)
31. T.J. Marrie, D.E. Low, E. De Carolis Canadian Community-Acquired Pneumonia Investigators A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology - results from a Canadian multicentre study Can Respir J 10 2003 368 374 (Pubitemid 37441565)
32. F. Arnold, A. LaJoie, T. Marrie, P. Rossi, F. Blasi, and C. Luna et al. The pneumonia severity index predicts time to clinical stability in patients with community-acquired pneumonia Int J Tuberc Lung Dis 10 2006 739 743 (Pubitemid 44031386)
33. R. Menéndez, R. Martinez, S. Reyes, J. Mensa, E. Polverino, and X. Filella et al. Stability in community-acquired pneumonia: one step forward with markers? Thorax 64 2009 987 992
34. N. Horita, N. Miyazawa, R. Kojima, N. Kimura, M. Inoue, and Y. Ishigatsubo et al. Sensitivity and specificity of the Streptococcus pneumoniae urinary antigen test for unconcentrated urine from adult patients with pneumonia: a meta-analysis Respirology 2013; Aug 2 10.1111/resp.12163 [Epub ahead of print]
35. D.M. Weinberger, Z.B. Harboe, E.A. Sanders, M. Ndiritu, K.P. Klugman, and S. Rückinger et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis Clin Infect Dis 51 2010 692 699